Latest news

Regulatory

Revolution Challenges Erasca’s ERAS-0015 Over Patent and Data Comparison Claims

Revolution Medicines has raised legal and competitive concerns against Erasca following recent developments in pancreatic cancer drug research. The...
Manufacturing

Lilly and Profluent Sign Up to $2.25 Billion Collaboration to Develop AI-Designed Genetic Medicines

Eli Lilly has entered into a multi-program research collaboration with California-based Profluent to develop genetic medicines using artificial intelligence-designed...
Clinical

Novartis and PTC Advance Huntington’s Drug Votoplam to Phase 3 Following Mid-Stage Data

Novartis and PTC Therapeutics have moved their Huntington’s disease candidate, votoplam, into Phase 3 development after results from a...
Commercial

Chiesi to Acquire KalVista for $1.9 Billion, Adding Oral HAE Therapy Ekterly

Italy-based Chiesi Group has agreed to acquire KalVista Pharmaceuticals in a deal valued at approximately $1.9 billion, securing access...
Insights

Top 10 Pharma Companies Leading Innovation in Drug Development (2026)

Executive Summary Drug development in 2026 is undergoing a structural...
Uncategorized

Top 10 Emerging Trends in Life Sciences for 2026

Emerging Trends:Executive Summary The life sciences industry in 2026 is...
Insights

Top 10 Breakthrough Therapies Shaping the Future of Medicine (2026)

Executive Summary The therapeutic landscape in 2026 is undergoing a fundamental transformation, driven by next-generation modalities, platform-based innovation, and precision...
Commercial

Lilly Continues Good M&A Run With $2.3B Deal For JAK Inhibitor Biotech Ajax

Eli Lilly continues its rapid pace of dealmaking, announcing the acquisition of Ajax Therapeutics to gain access to a...
Clinical

Oruka Therapeutics Reports Phase 2a Psoriasis Data Showing 63.5% Skin Clearance with ORKA-001

Oruka Therapeutics reported interim results from a phase 2a study of its experimental monoclonal antibody ORKA-001 in patients with...
Manufacturing

Avalyn Files for IPO Targeting Up to $209.7 Million to Advance Inhaled Lung Therapies

Avalyn Pharma, a Boston-based company focused on inhaled therapies...
Clinical

TIGIT dream fails in phase three, Gilead breaks off its relationship with Arcus

The domvanalimab, an anti-TIGIT antibody from Gilead Sciences and...
Clinical

Merck and Eisai Three-Drug Combination Therapy Fails to Meet Survival Endpoints in Phase 3 RCC Trial

A late-stage clinical trial evaluating a three-drug combination for renal cell carcinoma (RCC) did not achieve its primary objectives,...
Manufacturing

Replimune Cuts 224 Jobs in Massachusetts After Second FDA Rejection of RP1

Replimune is reducing its workforce by 224 employees across its Massachusetts operations following the U.S. Food and Drug Administration’s...
Clinical

Actuate Therapeutics medication increases survival chances in pancreatic cancer trial

Results of a mid-stage trial reported that twice as many patients with advanced pancreatic cancer treated with an experimental...
Regulatory

Revolution Challenges Erasca’s ERAS-0015 Over Patent and Data Comparison Claims

Revolution Medicines has raised legal and competitive concerns against...
Editorial Team -
Commercial

Chiesi to Acquire KalVista for $1.9 Billion, Adding Oral HAE Therapy Ekterly

Italy-based Chiesi Group has agreed to acquire KalVista Pharmaceuticals...
Editorial Team -
Commercial

Alnylam’s RNA drug gets FDA approval as a Pfizer face-off may be expected

Alnylam’s vutrisiran has gotten the green light from FDA,...
Commercial

Orion signs $16 million deal with Jemincare for development of novel non-opioid pain treatment

Orion deal with Jemincare involves a $16 million payment...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team -

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers...
Editorial Team -

Regulatory

Regulatory

Revolution Challenges Erasca’s ERAS-0015 Over Patent and Data Comparison Claims

Revolution Medicines has raised legal and competitive concerns against...
Editorial Team -
Manufacturing

Lilly and Profluent Sign Up to $2.25 Billion Collaboration to Develop AI-Designed Genetic Medicines

Eli Lilly has entered into a multi-program research collaboration...
Clinical

Novartis and PTC Advance Huntington’s Drug Votoplam to Phase 3 Following Mid-Stage Data

Novartis and PTC Therapeutics have moved their Huntington’s disease...
Commercial

Chiesi to Acquire KalVista for $1.9 Billion, Adding Oral HAE Therapy Ekterly

Italy-based Chiesi Group has agreed to acquire KalVista Pharmaceuticals...
Commercial

Teva Pens Deal Worth Over $700M to Buy Emalex

Teva Pharmaceuticals has agreed to acquire Emalex Biosciences in...

Research & Development

Market Access

Manufacturing

U.S. Biopharma Companies Advance Over $370B in Manufacturing and R&D Investments

Major drugmakers have announced more than $370 billion in...
Manufacturing

Novartis Plans 550 Layoffs in Switzerland While Expanding U.S. Manufacturing Footprint

 550 Layoffs ;Novartis has outlined several updates to its...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Regulatory

Revolution Challenges Erasca’s ERAS-0015 Over Patent and Data Comparison Claims

Revolution Medicines has raised legal and competitive concerns against...
Editorial Team -
Manufacturing

Avalyn Files for IPO Targeting Up to $209.7 Million to Advance Inhaled Lung Therapies

Avalyn Pharma, a Boston-based company focused on inhaled therapies...
Editorial Team -
Clinical

Novartis and PTC Advance Huntington’s Drug Votoplam to Phase 3 Following Mid-Stage Data

Novartis and PTC Therapeutics have moved their Huntington’s disease...
Editorial Team -